天津医药
天津醫藥
천진의약
Tianjin Medical Journal
2015年
10期
1162-1165
,共4页
吴晓东%齐新%侯文广%刘玥
吳曉東%齊新%侯文廣%劉玥
오효동%제신%후문엄%류모
心力衰竭%心室重构%胱抑素C%心肾综合征%N末端B型利钠肽原
心力衰竭%心室重構%胱抑素C%心腎綜閤徵%N末耑B型利鈉肽原
심력쇠갈%심실중구%광억소C%심신종합정%N말단B형리납태원
heart failure%ventricular remodeling%cystatin C%cardiorenal syndrome%NT-proBNP
目的:探讨血清胱抑素C(Cys C)在慢性心力衰竭(CHF)患者中的表达水平及其与心功能、心室重构的关系。方法入选CHF患者75例为CHF组,按照NYHA分级分为NYHAⅡ、Ⅲ、Ⅳ级组;按照血清Cys C水平分组:Cys C>0.95 mg/L为Cys C水平升高组,Cys C≤0.95 mg/L者为Cys C正常组;按照左室射血分数(LVEF)分组:LVEF≥0.50为LVEF保留组,LVEF<0.50为非LVEF保留组;入选35例老年健康体检者为对照组。分别测定Cys C、N末端B型利钠肽原(NT-proBNP)、血肌酐(Scr)、尿素(UREA)、心脏彩超等指标,并进行相关性分析。结果 CHF组患者血清Cys C水平明显高于对照组,且随着NYHA心功能分级增高,其水平也随之升高;与Cys C正常组比,Cys C水平升高组NT-proBNP较高,而LVEF较低(均P<0.05);与非LVEF保留组比,LVEF保留组NT-proBNP、左室舒张末容积(LVEDD)、左室质量指数(LVMI)、Cys C较低(均P<0.05);Cys C与年龄、NT-proBNP、LVEF、LVEDD、Scr、UREA相关(r分别为0.411、0.658、-0.465、0.310、0.552、0.486,P<0.01)。结论血清Cys C可用于评估早期心衰患者的心功能状况,与心室重构相关。
目的:探討血清胱抑素C(Cys C)在慢性心力衰竭(CHF)患者中的錶達水平及其與心功能、心室重構的關繫。方法入選CHF患者75例為CHF組,按照NYHA分級分為NYHAⅡ、Ⅲ、Ⅳ級組;按照血清Cys C水平分組:Cys C>0.95 mg/L為Cys C水平升高組,Cys C≤0.95 mg/L者為Cys C正常組;按照左室射血分數(LVEF)分組:LVEF≥0.50為LVEF保留組,LVEF<0.50為非LVEF保留組;入選35例老年健康體檢者為對照組。分彆測定Cys C、N末耑B型利鈉肽原(NT-proBNP)、血肌酐(Scr)、尿素(UREA)、心髒綵超等指標,併進行相關性分析。結果 CHF組患者血清Cys C水平明顯高于對照組,且隨著NYHA心功能分級增高,其水平也隨之升高;與Cys C正常組比,Cys C水平升高組NT-proBNP較高,而LVEF較低(均P<0.05);與非LVEF保留組比,LVEF保留組NT-proBNP、左室舒張末容積(LVEDD)、左室質量指數(LVMI)、Cys C較低(均P<0.05);Cys C與年齡、NT-proBNP、LVEF、LVEDD、Scr、UREA相關(r分彆為0.411、0.658、-0.465、0.310、0.552、0.486,P<0.01)。結論血清Cys C可用于評估早期心衰患者的心功能狀況,與心室重構相關。
목적:탐토혈청광억소C(Cys C)재만성심력쇠갈(CHF)환자중적표체수평급기여심공능、심실중구적관계。방법입선CHF환자75례위CHF조,안조NYHA분급분위NYHAⅡ、Ⅲ、Ⅳ급조;안조혈청Cys C수평분조:Cys C>0.95 mg/L위Cys C수평승고조,Cys C≤0.95 mg/L자위Cys C정상조;안조좌실사혈분수(LVEF)분조:LVEF≥0.50위LVEF보류조,LVEF<0.50위비LVEF보류조;입선35례노년건강체검자위대조조。분별측정Cys C、N말단B형리납태원(NT-proBNP)、혈기항(Scr)、뇨소(UREA)、심장채초등지표,병진행상관성분석。결과 CHF조환자혈청Cys C수평명현고우대조조,차수착NYHA심공능분급증고,기수평야수지승고;여Cys C정상조비,Cys C수평승고조NT-proBNP교고,이LVEF교저(균P<0.05);여비LVEF보류조비,LVEF보류조NT-proBNP、좌실서장말용적(LVEDD)、좌실질량지수(LVMI)、Cys C교저(균P<0.05);Cys C여년령、NT-proBNP、LVEF、LVEDD、Scr、UREA상관(r분별위0.411、0.658、-0.465、0.310、0.552、0.486,P<0.01)。결론혈청Cys C가용우평고조기심쇠환자적심공능상황,여심실중구상관。
Objective To explore serum Cystain C (Cys C) level in chronic heart failure (CHF) patients and its relation?ship with cardiac function and ventricular remodeling. Methods Patients with heart failure (n=75) and healthy adult (n=35) were enrolled in this study. According to the NYHA classification,CHF patients is divided into NYHA Ⅱ, NYHAⅢand NYHAⅣ;CHF patients can also be divided into 2 groups base on their level of serum Cys C:Cys C>0.95 mg/L is defined as elevated serum Cys C group, serum Cys C≤0.95 mg/L is defined as normal serum Cys C group;According to left ventricu?lar ejection fraction (LVEF), CHF patients can also be divided into 2 groups:LVEF≥0.50 is defined as ejection fraction re?served group, LVEF<0.50 is defined as the ejection fraction reduced group. Cys C, N terminal B-type natriuretic peptide (NT-proBNP), serum creatinine(Scr),UREA and Echocardiography were analyzed in all groups and their correlation was studied. Results Serum Cys C level in CHF patients was obviously higher than that in healthy controls, and it increased with NYHA heart function classification;compared with normal Cys C group,Cys C elevated group presented higher NT-proBNP level but lower eGFR and LVEF (P<0.05);compared with ejection fraction reduced group, ejection fraction reserved group demonstrated lower NT-proBNP, LVEDD, LVMI and Cys C levels (all P<0.05);Correlation analysis revealed that Cys C is correlated with age, NT-proBNP, LVEF, LVEDD, Scr and UREA (r=0.411, 0.658, 0.465, 0.310, 0.552, 0.486, P<0.01). Conclusion Serum Cys C can be used to evaluate cardiac function of heart failure, and is associated with ventricular remodeling.